promising

Breakthrough T1DSpotlight on OPF-310: A porcine-derived cell therapy in clinical trialsOne of our most promising avenues toward cures for type 1 diabetes is cell therapies. Learn more about one of …

A study from the University of Alabama at Birmingham is looking into a drug-free approach to treat type 2 diabetes. The research …

On January 6th, 2026, Encellin (California, Quebec) reported positive interim results of its Phase 1 clinical trial of encapsulated islets in people with type 1 diabetes (T1D), which is being carried …

NEW YORK, Nov. 6, 2025 /PRNewswire/ — Results of the Bayer-led Phase 3 FINE-ONE clinical trial, presented at the American Society of Nephrology Kidney Week in Houston, demonstrate that finerenone significantly …

In a groundbreaking development destined to reshape diabetes treatment paradigms, scientists from the University at Albany and the NYU Grossman School of Medicine have unraveled a critical molecular mechanism fueling …

UAMS has implemented a family-centered diabetes self-management education and support program designed to suit the cultural values ​​of the Marshall community. Fayetteville, Arkansas – Health professionals are tackling the Marshall …

Introduction Diabetes mellitus (DM) is a long-term chronic disease. According to recently published data from the International Diabetes Federation, the number of people worldwide suffering from diabetes has reached 451 …

An ongoing Phase I/II clinical trial is evaluating VX-880 as a treatment for type 1 diabetes (T1D). Image courtesy of Ahmet Misirligul/Shutterstock. Vertex Pharmaceuticals The company announced positive data from …